相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Mouse Models of Nonalcoholic Steatohepatitis: Toward Optimization of Their Relevance to Human Nonalcoholic Steatohepatitis
Geoff Farrell et al.
HEPATOLOGY (2019)
OPTN/SRTR 2017 Annual Data Report: Liver
W. R. Kim et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2019)
Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease
Chris Estes et al.
HEPATOLOGY (2018)
Mechanisms of NAFLD development and therapeutic strategies
Scott L. Friedman et al.
NATURE MEDICINE (2018)
Natural History of Nonalcoholic Fatty Liver Disease: A Prospective Follow-Up Study With Serial Biopsies
Patrik Nasr et al.
HEPATOLOGY COMMUNICATIONS (2018)
Mechanisms of hepatic stellate cell activation
Takuma Tsuchida et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2017)
Cause, Pathogenesis, and Treatment of Nonalcoholic Steatohepatitis
Anna M. Diehl et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Hepatocyte TAZ/WWTR1 Promotes Inflammation and Fibrosis in Nonalcoholic Steatohepatitis
Xiaobo Wang et al.
CELL METABOLISM (2016)
p38γ and p38δ reprogram liver metabolism by modulating neutrophil infiltration
Barbara Gonzalez-Teran et al.
EMBO JOURNAL (2016)
Exposure to Human Immunodeficiency Virus/Hepatitis C Virus in Hepatic and Stellate Cell Lines Reveals Cooperative Profibrotic Transcriptional Activation Between Viruses and Cell Types
Shadi Salloum et al.
HEPATOLOGY (2016)
The Hippo pathway effector YAP controls mouse hepatic stellate cell activation
Inge Mannaerts et al.
JOURNAL OF HEPATOLOGY (2015)
Accumulation of duct cells with activated YAP parallels fibrosis progression in non-alcoholic fatty liver disease
Mariana Verdelho Machado et al.
JOURNAL OF HEPATOLOGY (2015)
Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: Implications for prognosis and clinical management
Stuart McPherson et al.
JOURNAL OF HEPATOLOGY (2015)
Hippo Pathway Activity Influences Liver Cell Fate
Dean Yimlamai et al.
CELL (2014)
CCN1 expression in hepatocytes contributes to macrophage infiltration in nonalcoholic fatty liver disease in mice
Zhaolian Bian et al.
JOURNAL OF LIPID RESEARCH (2013)
Prevalence of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Among a Largely Middle-Aged Population Utilizing Ultrasound and Liver Biopsy: A Prospective Study
Christopher D. Williams et al.
GASTROENTEROLOGY (2011)
The Merlin/NF2 Tumor Suppressor Functions through the YAP Oncoprotein to Regulate Tissue Homeostasis in Mammals
Nailing Zhang et al.
DEVELOPMENTAL CELL (2010)
Hepatic Lipotoxicity and the Pathogenesis of Nonalcoholic Steatohepatitis: the Central Role of Nontriglyceride Fatty Acid Metabolites
Brent A. Neuschwander-Tetri
HEPATOLOGY (2010)
In vivo regulation of Yorkie phosphorylation and localization
Hyangyee Oh et al.
DEVELOPMENT (2008)
TAZ promotes cell proliferation and epithelial-mesenchymal transition and is inhibited by the hippo pathway
Qun-Ying Lei et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control
Bin Zhao et al.
GENES & DEVELOPMENT (2007)
Prolonged treatment of primary Hepatocytes with oleate induces insulin resistance through p38 mitogen-activated protein kinase
Hui-Yu Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
p38 mitogen-activated protein kinase mediates free fatty acid-induced gluconeogenesis in hepatocytes
Qu Fan Collins et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases
GL Johnson et al.
SCIENCE (2002)
分享论文
